Merit Medical Systems EBITDA 2010-2024 | MMSI

Merit Medical Systems annual and quarterly EBITDA history from 2010 to 2024. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
  • Merit Medical Systems EBITDA for the quarter ending September 30, 2024 was $0.068B, a 9.62% increase year-over-year.
  • Merit Medical Systems EBITDA for the twelve months ending September 30, 2024 was $0.267B, a 21.82% increase year-over-year.
  • Merit Medical Systems 2023 annual EBITDA was $0.227B, a 25.85% increase from 2022.
  • Merit Medical Systems 2022 annual EBITDA was $0.18B, a 14.67% increase from 2021.
  • Merit Medical Systems 2021 annual EBITDA was $0.157B, a 48.68% increase from 2020.
Merit Medical Systems Annual EBITDA
(Millions of US $)
2023 $227
2022 $180
2021 $157
2020 $106
2019 $120
2018 $129
2017 $87
2016 $79
2015 $76
2014 $77
2013 $61
2012 $52
2011 $52
2010 $32
2009 $45
Merit Medical Systems Quarterly EBITDA
(Millions of US $)
2024-09-30 $68
2024-06-30 $74
2024-03-31 $64
2023-12-31 $61
2023-09-30 $62
2023-06-30 $54
2023-03-31 $50
2022-12-31 $54
2022-09-30 $42
2022-06-30 $46
2022-03-31 $38
2021-12-31 $46
2021-09-30 $40
2021-06-30 $33
2021-03-31 $39
2020-12-31 $43
2020-09-30 $27
2020-06-30 $8
2020-03-31 $28
2019-12-31 $23
2019-09-30 $24
2019-06-30 $38
2019-03-31 $35
2018-12-31 $33
2018-09-30 $39
2018-06-30 $33
2018-03-31 $24
2017-12-31 $28
2017-09-30 $15
2017-06-30 $26
2017-03-31 $18
2016-12-31 $25
2016-09-30 $15
2016-06-30 $22
2016-03-31 $18
2015-12-31 $18
2015-09-30 $18
2015-06-30 $22
2015-03-31 $18
2014-12-31 $24
2014-09-30 $21
2014-06-30 $16
2014-03-31 $15
2013-12-31 $20
2013-09-30 $17
2013-06-30 $15
2013-03-31 $10
2012-12-31 $10
2012-09-30 $15
2012-06-30 $14
2012-03-31 $13
2011-12-31 $11
2011-09-30 $11
2011-06-30 $15
2011-03-31 $15
2010-12-31 $10
2010-09-30 $0
2010-06-30 $12
2010-03-31 $10
2009-12-31 $11
2009-09-30 $12
2009-06-30 $12
2009-03-31 $11
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $5.611B $1.257B
Merit Medical Systems, Inc. provides various peripheral and cardiac intervention products to cure cardiac conditions specific to interventional cardiology and electrophysiology. The company offers products focused in five core product groups: peripheral intervention, cardiac intervention, interventional oncology and spine, cardiovascular and critical care as well as endoscopy. However, the company operates in two revenue segments: Cardiovascular and Endoscopy Devices.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.526B 20.06
Becton Dickinson (BDX) United States $64.714B 17.01
Cardinal Health (CAH) United States $28.315B 15.35
West Pharmaceutical Services (WST) United States $23.683B 48.37
Labcorp (LH) United States $18.984B 15.74
Cooper (COO) United States $18.348B 24.85
Align Technology (ALGN) United States $15.944B 30.51
Henry Schein (HSIC) United States $8.597B 16.38
DENTSPLY SIRONA (XRAY) United States $3.671B 9.98
Patterson (PDCO) United States $2.730B 14.58
CONMED (CNMD) United States $2.162B 18.04
STAAR Surgical (STAA) United States $1.231B 45.42
Lifevantage (LFVN) United States $0.222B 29.55
Pro-Dex (PDEX) United States $0.151B 30.10